SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-066907
Filing Date
2014-11-06
Accepted
2014-11-06 10:16:08
Documents
2
Period of Report
2014-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5698
2 EX-24 DOCUMENT attachment1.htm EX-24 4330
  Complete submission text file 0001209191-14-066907.txt   12486
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36721 | Film No.: 141199231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Reporting) CIK: 0001575852 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36721 | Film No.: 141199230